| Filed On | Filing |
|---|---|
| 08 Jan 2025 |
Form 3: Sanders Reginald J., Director
No securities owned |
| 05 Sep 2024 |
Form 3: Hassan Fred, Director
No securities owned |
| 22 Apr 2024 |
Form 3: Adage Capital Management, L.p., 10% owner and 2 others
Holds 5,156,299 shares of Common Stock, par value $0.001 per share ("Common Stock") |
| 04 Mar 2024 |
Form 3: Ribeiro Ramiro, Chief Medical Officer
No securities owned |
| 06 Dec 2023 |
Form 3: Cormorant Asset Management, Lp, 10% owner and 2 others
Holds 3,530,943 shares of Common Stock |
| 17 Oct 2023 |
Form 3: Duty Stuart, Director
No securities owned |
| 13 Jul 2022 |
Form 3: Zaderej Karen L., Director
No securities owned |
| 27 Jun 2022 |
Form 3: Adamis Anthony P, Director
No securities owned |
| 14 Jan 2022 |
Form 3: Pine Michael Craig, Chief Corp Dev.&Strat. Officer
No securities owned |
| 03 Nov 2021 |
Form 3: Duker Jay S., Chief Operating Officer
Holds 5,657 shares of Common Stock |
| 14 Jan 2021 |
Form 3: OcuMension Therapeutics, 10% owner
Holds 3,010,722 shares of Common Stock, $0.001 par value |
| 13 Jan 2021 |
Form 3: Liu Ye, Director
Holds 3,010,722 shares of Common Stock, $0.001 par value |
| 18 Nov 2019 |
Form 3: Elston George, Chief Financial Officer
No securities owned |
| 16 Jul 2019 |
Form 3: Dicicco Wendy F, Director
No securities owned |
| 12 Jun 2019 |
Form 3: Jones David Scott, SVP & Chief Commercial Officer
No securities owned |
| 29 Jan 2019 |
Form 3: Guyer David R, Director
No securities owned |
| 29 Oct 2018 |
Form 3: Landis John B., Director
No securities owned |
| 03 Aug 2018 |
Form 3: Price David, Chief Financial Officer
No securities owned |
| 27 Jun 2018 |
Form 3: Ando Goran, Director
No securities owned |
| 16 May 2018 |
Form 3: Blum Leonard M, See Remarks
No securities owned |
Loading...